Onsdag 11 Februari | 23:08:33 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-02-04 20:30 Bokslutskommuniké 2026
2026-10-22 20:30 Kvartalsrapport 2026-Q3
2026-07-17 20:30 Kvartalsrapport 2026-Q2
2026-05-08 N/A X-dag ordinarie utdelning TOBII 0.00 SEK
2026-05-07 N/A Årsstämma
2026-05-06 20:30 Kvartalsrapport 2026-Q1
2026-02-04 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-07-29 - Kvartalsrapport 2025-Q2
2025-05-28 - Årsstämma
2025-05-12 - X-dag ordinarie utdelning TOBII 0.00 SEK
2025-05-07 - Kvartalsrapport 2025-Q1
2025-02-04 - Bokslutskommuniké 2024
2025-01-10 - Extra Bolagsstämma 2025
2024-10-25 - Kvartalsrapport 2024-Q3
2024-07-19 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning TOBII 0.00 SEK
2024-05-23 - Årsstämma
2024-05-16 - Kvartalsrapport 2024-Q1
2024-03-04 - Extra Bolagsstämma 2024
2024-02-01 - Bokslutskommuniké 2023
2023-11-07 - Kvartalsrapport 2023-Q3
2023-07-21 - Kvartalsrapport 2023-Q2
2023-05-29 - X-dag ordinarie utdelning TOBII 0.00 SEK
2023-05-26 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-07 - Bokslutskommuniké 2022
2022-11-08 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning TOBII 0.00 SEK
2022-05-25 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-08 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-10-25 - Extra Bolagsstämma 2021
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-19 - X-dag ordinarie utdelning TOBII 0.00 SEK
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-04 - Bokslutskommuniké 2020
2020-10-29 - Kvartalsrapport 2020-Q3
2020-08-19 - Kvartalsrapport 2020-Q2
2020-05-13 - X-dag ordinarie utdelning TOBII 0.00 SEK
2020-05-12 - Årsstämma
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-06 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning TOBII 0.00 SEK
2019-05-09 - Årsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
2019-02-06 - Bokslutskommuniké 2018
2018-10-25 - Kvartalsrapport 2018-Q3
2018-07-20 - Kvartalsrapport 2018-Q2
2018-05-09 - X-dag ordinarie utdelning TOBII 0.00 SEK
2018-05-08 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-02-08 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-07-25 - Kvartalsrapport 2017-Q2
2017-05-10 - X-dag ordinarie utdelning TOBII 0.00 SEK
2017-05-09 - Årsstämma
2017-04-27 - Kvartalsrapport 2017-Q1
2017-02-15 - Bokslutskommuniké 2016
2016-11-30 - Extra Bolagsstämma 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-07-28 - Kvartalsrapport 2016-Q2
2016-05-12 - X-dag ordinarie utdelning TOBII 0.00 SEK
2016-05-11 - Årsstämma
2016-05-04 - Kvartalsrapport 2016-Q1
2016-02-16 - Bokslutskommuniké 2015
2015-11-03 - Kvartalsrapport 2015-Q3
2015-08-05 - Kvartalsrapport 2015-Q2
2015-06-10 - Årsstämma
2015-05-22 - Kvartalsrapport 2015-Q1
2015-05-20 - Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorInformationsteknik
IndustriElektronisk utrustning
Tobii är verksamt inom IT-sektorn. Bolaget utvecklar tekniska lösningar för eye-tracking, som gör det möjligt för datorer att veta vart användaren tittar. Olika lösningar som bolaget utvecklar är kommunikationslösningar för personer med rörelsehinder eller kommunikationssvårigheter, samt tillhörande utrustning inom arbetsområdet. Kunder återfinns huvudsakligen inom forskningsinstitut, tillbehör inom VR för speldatorer, samt inom sjukvård. Huvudkontoret ligger i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-02-11 09:30:00

The eye tracking-based autism spectrum disorder screening tool aims to enable earlier detection and treatment through scientifically designed eye tracking tests.

Tobii, the global leader in eye tracking and pioneer of attention computing has secured a design win for Get Set Early, an autism spectrum disorder (ASD) screening tool designed to uncover early signs of autism in children as young as 12 months. The screening tool, developed by Psychology professor Dr. Karen Pierce and her team at UC San Diego and expanded by Butterfly Learnings, is the first of its kind in India to receive a CDSO certification and be approved for clinical use.

Early detection critical for effective therapy

Research shows that children diagnosed with autism before age two experience better language, cognitive, and social development. The brain is most adaptable in the first few years of life, making early detection crucial for effective therapy. Get Set Early enables early detection through the non-invasive nature of the test, letting children watch a short video while the system tracks eye movements to measure how long they focus on different types of stimuli. From this test, objective biomarkers for autism spectrum disorder are provided, making the assessment reliable and unbiased. The test is based on a patented and scientifically validated method that uses eye movements to detect signs of autism in children, developed by Dr. Karen Pierce, co-Director of Autism Center of Excellence, University of California, San Diego.

“Partnering with Tobii allows us to deliver gold-standard eye-tracking diagnostics for early autism screening across India and global markets. This is a powerful step forward in our mission to make high-quality, technology-driven screening accessible to every child, everywhere. We look forward to scaling this partnership globally.” said Abhishek Sen, Co-Founder & CEO, Butterfly Learnings.

Eye tracking enabled by the Tobii Eye Tracker 5L

Tobii will provide Butterfly Learnings with the Tobii Eye Tracker 5L for integration into the Get Set Early screening tool. The Tobii Eye Tracker 5L is a high-performance eye tracker designed for seamless integration into digital health platforms, diagnostic tools, and cognitive assessment products.

“It’s an honor for Tobii to be part of a product that can really make a change in people’s lives. We are truly impressed with what Butterfly Learnings have achieved with the Get Set Early tool, building on fundamental research insights and converting them into real world use that is clinically approved, accessible, and scalable.” said Emma Bauer, senior vice president, Integrations, at Tobii.

The Get Set Early screening tool is currently being implemented out across clinics all over India. For the development and integration of Tobii’s Eye tracking technology into the screening tool, Butterfly Learnings and Tobii worked together with Tiden Technologies, the Indian reseller of Tobii’s products, specialized in research grade technologies for neuroscience.

You can learn more about Tobii Eye Tracker 5L here.

For more information, please contact:
Rasmus Löwenmo Buckhöj, Head of Communications, Tobii AB, phone: +46 (0)73 327 87 64, email: rasmus.lowenmobuckhoj@tobii.com

About Tobii 
Tobii is the global leader in eye tracking and pioneer of attention computing. We are on a mission to improve the world with technology that understands human attention and intent. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Tobii's eye tracking is used by thousands of enterprises, universities, and research institutes around the globe. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com. 

About Butterfly Learnings:
Butterfly Learnings is a healthcare-led neurodevelopmental platform focused on early identification, therapy, and inclusive education for children with developmental and learning differences. Built on evidence-based clinical practices, Butterfly integrates diagnostics, multidisciplinary therapy, and school readiness programs to deliver measurable outcomes for children and families. With a strong emphasis on early intervention, clinical rigor, and scalable delivery, Butterfly Learnings works closely with pediatricians, therapists, and educators to ensure timely support during the most critical years of brain development
www.butterflylearnings.com

About Tiden Technologies
Tiden Technologies specializes in advanced human behavioral and neuroscientific technologies, including eye tracking and neuro-sensing solutions. As Tobii AB’s regional distribution partner, it has enabled widespread adoption of eye-tracking applications across academic research, healthcare, defense, UX, and automotive sectors. For further information visit: www.tidentech.com